By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > GMJ Briefs > $101 Million Prize Pool Fuels Race for Age Reversal Breakthroughs

$101 Million Prize Pool Fuels Race for Age Reversal Breakthroughs

GMJ
Last updated: 12/06/2026 17:21
By
Prof. Giorgi Pkhakadze
Share
1 Min Read
Scientific researchers working on longevity interventions in laboratory setting
The XPRIZE Healthspan competition offers $101 million in prizes for age reversal breakthroughs targeting cognitive, muscle, and immune function. Dr. Jamie Justice leads scientific oversight of the world's largest longevity research initiative. — Photo: Mike van Schoonderwalt / Pexels
SHARE
1 min read|132 words

The XPRIZE Healthspan competition has allocated $101 million in prize funding specifically designed to accelerate longevity research breakthroughs. The prize distribution reflects strategic prioritization: cognitive function restoration ($20M), muscle function recovery ($20M), immune function enhancement ($20M), milestone achievements ($14M), and audacious research goals ($11M).

This substantial financial commitment has attracted leading research teams from major institutions globally, each pursuing measurable interventions to restore functional capacity in aging populations. Dr. Jamie Justice, the competition’s scientific director, explains that teams must demonstrate concrete improvements in older adults across defined timeframes. Research directions showing significant early promise include cellular reprogramming approaches and targeted metabolic interventions. The competition structure incentivizes both incremental progress through milestone prizes and transformative breakthroughs through grand prizes, reflecting a comprehensive approach to advancing aging science. Read the full article on GMJ Newsroom.

Was this article helpful?

GMJ Brief · Key Finding

📰 Read the full article: World’s Largest Longevity Competition Targets Age Reversal Breakthroughs →

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Oral GLP-1 Drug Achieves 11.3% Weight Loss in Phase 2 Trial

Phase 2b trial shows oral GLP-1 drug aleniglipron achieved 11.3% weight loss…

AI-Enhanced Scans and Immune-Targeting Drugs Transform Heart Inflammation Detection

AI-enhanced imaging and immune-targeting drugs are revolutionizing cardiac inflammation detection and treatment.…

Spinal Cord Stimulation Shows Promise for Stroke Recovery in Small Trial

Small clinical trial shows epidural spinal cord stimulation safely improved arm function…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

PHEIC Declaration: Ebola Cross-Border Transmission DRC-Uganda

By
Prof. Giorgi Pkhakadze
31/05/2026
Children laughing during therapeutic play session showing brain development benefits

Middlesex University Study Identifies Laughter as Potent Tool for Pediatric Brain Development

By
Prof. Giorgi Pkhakadze
04/06/2026
Medical catheter device with FDA safety warning symbol

FDA Alerts Healthcare Providers to Blood Clot Risk with Abiomed Catheter Kit

By
Prof. Giorgi Pkhakadze
12/06/2026

PHEIC Declaration: Cross-Border Ebola Outbreak DRC-Uganda

By
Prof. Giorgi Pkhakadze
31/05/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up